GLYRX-PF
- Product NDC
- 51754-6013
- 11-digit product format
- 517546013
- Labeler code
- 51754
- Product ID
- 51754-6013_442634f7-9858-421d-91db-5bfdb21dcf13
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- glycopyrrolate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Exela Pharma Sciences, LLC
- Application
- NDA210997
- Marketing category
- NDA
- Marketing start
- 2020-06-01
- Substance
- GLYCOPYRROLATE
- Active strength
- .2 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V92SO9WP2I | GLYCOPYRROLATE | 51186-83-5 | GLYCOPYRROLATE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 51754-6013-3 | 51754601303 | 10 SYRINGE, PLASTIC in 1 CARTON (51754-6013-3) / 3 mL in 1 SYRINGE, PLASTIC | 2020-12-15 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| GLYRX-PF | Exela Pharma Sciences, LLC | 2025-07-23 | HUMAN PRESCRIPTION DRUG LABEL | 5 |